COVID-19 update: An EUA for vilobelimab (Gohibic) for COVID-19.

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

COVID-19 update: An EUA for vilobelimab (Gohibic) for COVID-19.

Med Lett Drugs Ther ; 65(1677): 86-87, 2023 05 29.

Article in English | MEDLINE | ID: covidwho-2321651

Subject(s)

COVID-19; Humans; Antibodies, Monoclonal

Keywords

Actemra; COVID-19; Gohibic; Olumiant; Veklury; adverse effects; baricitinib; dexamethasone; dosage; efficacy; pregnancy; remdesivir; safety; tocilizumab; vilobelimab

Fulltext

Print

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Med Lett Drugs Ther Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Med Lett Drugs Ther Year: 2023 Document Type: Article